- Home
- PMCB vs SBLX Comparison
PMCB vs SBLX Comparison
Compare PMCB & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SBLX
- Stock Information
- Founded
- PMCB 1996
- SBLX 2017
- Country
- PMCB United States
- SBLX United States
- Employees
- PMCB N/A
- SBLX N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SBLX Telecommunications Equipment
- Sector
- PMCB Health Care
- SBLX Consumer Discretionary
- Exchange
- PMCB Nasdaq
- SBLX Nasdaq
- Market Cap
- PMCB 6.6M
- SBLX 6.0M
- IPO Year
- PMCB N/A
- SBLX N/A
- Fundamental
- Price
- PMCB $0.80
- SBLX $3.62
- Analyst Decision
- PMCB
- SBLX
- Analyst Count
- PMCB 0
- SBLX 0
- Target Price
- PMCB N/A
- SBLX N/A
- AVG Volume (30 Days)
- PMCB 42.7K
- SBLX 84.2K
- Earning Date
- PMCB 12-12-2025
- SBLX 11-11-2025
- Dividend Yield
- PMCB N/A
- SBLX N/A
- EPS Growth
- PMCB N/A
- SBLX N/A
- EPS
- PMCB 0.01
- SBLX N/A
- Revenue
- PMCB N/A
- SBLX N/A
- Revenue This Year
- PMCB N/A
- SBLX N/A
- Revenue Next Year
- PMCB N/A
- SBLX N/A
- P/E Ratio
- PMCB $125.04
- SBLX N/A
- Revenue Growth
- PMCB N/A
- SBLX N/A
- 52 Week Low
- PMCB $0.75
- SBLX $3.06
- 52 Week High
- PMCB $1.93
- SBLX $15.28
- Technical
- Relative Strength Index (RSI)
- PMCB 29.41
- SBLX 39.94
- Support Level
- PMCB $0.79
- SBLX $3.10
- Resistance Level
- PMCB $0.93
- SBLX $3.82
- Average True Range (ATR)
- PMCB 0.06
- SBLX 0.40
- MACD
- PMCB -0.01
- SBLX -0.04
- Stochastic Oscillator
- PMCB 16.01
- SBLX 35.70
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SBLX StableX Technologies Inc. Common Stock
StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.